Cargando…
Antifungals: From Pharmacokinetics to Clinical Practice
The use of antifungal drugs started in the 1950s with polyenes nystatin, natamycin and amphotericin B-deoxycholate (AmB). Until the present day, AmB has been considered to be a hallmark in the treatment of invasive systemic fungal infections. Nevertheless, the success and the use of AmB were associa...
Autores principales: | Carmo, Anália, Rocha, Marilia, Pereirinha, Patricia, Tomé, Rui, Costa, Eulália |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215229/ https://www.ncbi.nlm.nih.gov/pubmed/37237787 http://dx.doi.org/10.3390/antibiotics12050884 |
Ejemplares similares
-
Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients
por: Bellmann, Romuald, et al.
Publicado: (2017) -
Clinical practice update of antifungal prophylaxis in immunocompromised children
por: Ramos, José Tomás, et al.
Publicado: (2019) -
Extraction of Pharmacokinetic Evidence of Drug–Drug Interactions from the Literature
por: Kolchinsky, Artemy, et al.
Publicado: (2015) -
Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis
por: Novy, Emmanuel, et al.
Publicado: (2023) -
Pharmacokinetic/Pharmacodynamic Modeling and Application in Antibacterial and Antifungal Pharmacotherapy: A Narrative Review
por: Pereira, Laiz Campos, et al.
Publicado: (2022)